None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Working adults aged 19 to 64 2 Moderate stress group scoring 23 or higher on the Perceived Stress Scale 3 For working adults currently receiving medication for psychiatric conditions such as depression, anxiety disorders, or insomnia, the medication dosage must have remained unchanged for the past 6 months and is expected to remain stable during the clinical trial period 4 Voluntarily agreed to participate after fully understanding the clinical trial protocol
Exclusion criteria
Exclusion criteria: 1 Adults under 19 years of age or over 65 years of age 2 Individuals with dementia, intellectual disabilities, or other cognitive impairments 3 Individuals with convulsive disorders, stroke, or other neurological conditions 4 Individuals with psychotic disorders such as schizophrenia or bipolar I disorder, or a history thereof 5 Individuals currently experiencing suicidal thoughts 6 Individuals with conditions that may affect the reliability of HRV testing, such as heart disease or lung disease 7 Individuals currently receiving or who have received non-pharmacological psychiatric treatment, counseling, or meditation training within the past 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Perceived Stress Scale (PSS);Emotional Labor Scale (ELS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Health Questionnaire-9 (PHQ-9);Korean Occupational Stress Scale-Short Form (KOSS-SF);Connor-Davidson Resilience Scale-2 (CD-RISC2);Insomnia Severity Index (ISI);Positive and Negative Affect Schedule-Revised (K-PANAS-R);Maslach Burnout Inventory-General Survey (MBI-GS);Satisfaction With Life Scale (K-SWLS);Heart Rate Variability (HRV;Electroencephalography (EEG) | — |
Countries
Korea, Republic of
Contacts
Seoul National University Bundang Hospital